News
InvestorsHub on MSN14d
Nuwellis Shares Drop as Company Halts REVERSE-HF Clinical TrialNuwellis Inc (NASDAQ:NUWE) saw its stock decline by 10% after announcing it will discontinue its REVERSE-HF clinical trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback